| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 31,838 | 24,542 | 11,328 | | Cost of Revenue | 13,553 | 9,548 | 5,485 | | | Gross Profit | 18,285 | 14,994 | 5,843 | | | Operating Expenses | | Research Development | 2,377 | 1,837 | 1,244 | | Selling General and Administrative | 12,046 | 9,816 | 7,214 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 3,862 | 3,341 | (2,615) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 448 | 580 | 160 | | Earnings Before Interest And Taxes | 4,310 | 3,921 | (2,480) | | Interest Expense |
-
|
-
|
-
| | Income Before Tax | 4,310 | 3,921 | (2,480) | | Income Tax Expense | 971 | 1,044 | (239) | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 3,338 | 2,876 | (2,241) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 3,338 | 2,876 | (2,241) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $3,338 | $2,876 | ($2,241) |
|
1.48% Nasdaq 
Income Statement
